Form 4: TransMedics Group CEO Receives Stock Grant
Insider Transaction (Form 4)
Waleed H Hassanein, President & CEO and a Director of TransMedics Group, Inc., reported multiple transactions in common stock on July 10, 2026.
Summary
- Grant/award: acquired 49,669 Common Stock on July 10, 2026; holds 171,093 after (Direct).
- Grant/award: acquired 112,984 Stock Option (Right to Buy) on July 10, 2026; holds 112,984 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Waleed H Hassanein — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-10 | Grant/award | Common Stock | 49,669 | — | — | 171,093 |
| 2026-07-10 | Grant/award | Stock Option (Right to Buy) | 112,984 | — | — | 112,984 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-10 | Grant/award (49,669 shares) |
| 2026-07-10 | Grant/award (112,984 shares) |
Keywords
insider transaction, Form 4, TMDX, TransMedics Group, Inc., neutral, Waleed H Hassanein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.